Fosun Kite Biotechnology

Fosun Kite Biotechnology

Fosun Kite Biotechnology develops immune cell therapy products.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD124—185m (Dealroom.co estimates Jul 2020.)
Shanghai Shanghai (HQ)
  • Edit
DateInvestorsAmountRound

$20.0m

Late VC
Total FundingAUD30.9m

Recent News about Fosun Kite Biotechnology

Edit